Clinical Trial Update: Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluated the three-drug combination of erlotinib, docetaxel, and carboplatin in newly diagnosed Stage III or Stage IV ovarian epithelial canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Paraplatin (Carboplatin)
• Tarceva (erlotinib)
• Taxotere (docetaxel)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 1, Phase 2 | Status: COMPLETED